Subclinical left ventricular dysfunction in multiple sclerosis

Acta Neurologica Scandinavica

Volumn 114, Issue 2, 2006, Pages 114-118

  Akgül, Ferit ^a   Mclek, Ismet ^a   Duman, Taşkin ^a   Seyfelì, Ergün ^a   Seydaliyeva, Tunzale ^a   Yalçin, Fatih ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Multiple sclerosis; Tissue doppler; Ventricular function

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; HEART INDEX; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART PERFORMANCE; HEART RIGHT VENTRICLE FUNCTION; HUMAN; MALE; MULTIPLE SCLEROSIS; STATISTICAL SIGNIFICANCE; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; CARDIAC OUTPUT, LOW; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; MALE; MULTIPLE SCLEROSIS; MYOCARDITIS; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33745827432     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00662.x     Document Type: Article

References (23)

1. BETTS CD, D'MELLOW MT, FOWLER CJ. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry 1993;56:245-50.
2. MCDOUGALL AJ, MCLEOD JG. Autonomic nervous system function in multiple sclerosis. J Neurol Sci 2003;215:79-85.
3. SAVCI S, İNAL-İNCE D, ARIKAN H et al. Six-minute walk distance as a measure of functional exercise capacity in multiple sclerosis. Disabil Rehabil 2005;27:1365-71.
4. BEER M, SANDSTEDE J, WEILBACH F et al. Cardiac metabolism and function in patients with multiple sclerosis: a combined 31P-MR-spectroscopy and MRI study. Rofo 2001;173:399-404.
5. OLINDO S, GUILLON B, HELIAS J, PHILLIBERT B, MAGNE C, FEVE JR. Decrease in heart ventricular ejection fraction during multiple sclerosis. Eur J Neurol 2002;9:287-91.
6. SPINDLER M, WEILBACH F, BEER M et al. Non-invasive functional and biochemical assessment of mitoxantrone cardiotoxicity in patients with multiple sclerosis. J Cardiovasc Pharmacol 2003;42:680-7.
7. STROTMANN JM, SPINDLER M, WEILBACH FX, GOLD R, ERTL G, VOELKER W. Myocardial function in patients with multiple sclerosis treated with low-dose mitoxantrone. Am J Cardiol 2002;89:1222-5.
8. ZIABER J, CHMIELEWSKI H, DRYJANSKI T, GOCH JH. Evaluation of myocardial muscle functional parameters in patients with multiple sclerosis. Acta Neurol Scand 1997;95:335-7.
9. GALIUTO L, IGNONE G, DEMARIA AN. Contraction and relaxation velocities of the normal left ventricle using pulsed-wave tissue Doppler echocardiography. Am J Cardiol 1998;81:609-14.
10. HARADA K, TAMURA M, TOYONO M, OYAMA K, TAKADA G. Assessment of global left ventricular function by tissue Doppler imaging. Am J Cardiol 2001;88:927-32.
11. CACCIAPUOTI F, GALZERANO D, CAPOGROSSO P et al. Impairment of left ventricular function in systemic lupus erythematosus evaluated by measuring myocardial performance index with tissue Doppler echocardiography. Echocardiography 2005;22:315-9.
12. TEI C, DUJARDIN KS, HODGE DO, KYLE RA, TAJIK AJ, SEWARD JB. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol 1996;28:658-64.
13. POULSEN SH, JENSEN SE, NIELSEN JC, MOLLER JE, EGSTRUP K. Serial changes and prognostic implications of a Doppler-derived index of combined left ventricular systolic and diastolic myocardial performance in acute myocardial infarction. Am J Cardiol 2000;85:19-25.
14. POSER CM, PATY DW, SCHEINBERG L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
15. KURTZKE JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
16. QUIÑONES MA, OTTO CM, STODDARD M, WAGGONER A, ZOGHBI WA. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002;15:167-84.
17. DRORY VE, NISIPEANU PF, KROCZYN AD. Tests of autonomic dysfunction in patients with multiple sclerosis. Acta Neurol Scand 1995;92:356-60.
18. THOMAIDES TN, ZOUKOS Y, CHAUDHURI KR, MATHIAS CJ. Physiological assessment of aspects of autonomic function in patients with secondary progressive multiple sclerosis. J Neurol 1993;240:139-43.
19. VITA G, FAZIO MC, MILONE S, BLANDINO A, SALVI L, MESSINA C. Cardiovascular autonomic dysfunction in multiple sclerosis is likely related to brainstem lesions. J Neurol Sci 1993;120:82-6.
20. ISBISTER CM, MACKENZIE PJ, ANDERSON D, WADE NK, OGER J. Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia. Mult Scler 2003;9:550-3.
21. KARNI A, ABRAMSKY O. Association of MS with thyroid disorders. Neurology 1999;53:883-5.
22. ZEIN G, BERTA A, FOSTER CS. Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm 2004;12:137-42.
23. SIEVE AN, STEELMAN AJ, YOUNG CR et al. Chronic restraint stress during early Theiler's virus infection exacerbates the subsequent demyelinating disease in SJL mice. J Neuroimmunol 2004;155:103-18.